• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究从鼻腔给药系统中吸收美洛昔康及其盐形式的途径。

Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems.

机构信息

Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.

Department of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.

出版信息

Molecules. 2018 Mar 28;23(4):784. doi: 10.3390/molecules23040784.

DOI:10.3390/molecules23040784
PMID:29597330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6017030/
Abstract

The aim of this article was to study the trans-epithelial absorption to reach the blood and to target the brain by axonal transport using nasal formulations with nanonized meloxicam (nano MEL spray) and its salt form known as meloxicam potassium monohydrate (MELP spray). The physicochemical properties and the mucoadhesivity of nasal formulations were controlled. In vitro and in vivo studies were carried out. These forms were first investigated in "nose-to-brain" relation. It was found that the in vitro study and in vivo study did not show any significant correlation. In vitro experiments demonstrated faster dissolution rate and higher diffusion of MELP from the spray compared with the nano MEL spray. The administration of the nano MEL spray resulted in faster absorption and constant plasma concentration of the drug after five minutes of administration as compared to MELP. The axonal transport of the drug was justified. MEL appeared in the brain tissues after the first five minutes of administration in the case of both spray forms, but its amount was too small in comparison with the total plasma concentration. The application of the nano MEL spray resulted in the same AUC in the brain as the intravenous injection. The "nose-to-blood" results predicted the nasal applicability of MEL and MELP in pain management. The "nose-to-brain" pathway requires further study.

摘要

本文旨在研究经鼻制剂纳米化美洛昔康(纳米 MEL 喷雾)及其盐形式美洛昔康钾一水合物(MELP 喷雾)的跨上皮吸收到达血液并通过轴突运输靶向大脑的情况。控制了鼻用制剂的物理化学性质和黏膜黏附性。进行了体外和体内研究。首先研究了这些形式的“鼻-脑”关系。结果发现,体外研究和体内研究之间没有显著相关性。与纳米 MEL 喷雾相比,体外实验表明 MELP 喷雾具有更快的溶解速率和更高的扩散性。与 MELP 相比,纳米 MEL 喷雾给药后五分钟内药物吸收更快,血浆浓度保持稳定。药物的轴突运输得到了证明。在两种喷雾形式中,药物在给药后 5 分钟内就出现在脑组织中,但与总血浆浓度相比,其数量太少。纳米 MEL 喷雾的应用使脑内 AUC 与静脉注射相同。“鼻-血”结果预测了 MEL 和 MELP 在疼痛管理中的鼻用适用性。“鼻-脑”途径需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/1635e808f9ee/molecules-23-00784-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/4f7059eab6b1/molecules-23-00784-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/038676172f5f/molecules-23-00784-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/419a6acdef13/molecules-23-00784-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/b0da778f9274/molecules-23-00784-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/cd0c73f1c6a8/molecules-23-00784-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/c6c2850d7530/molecules-23-00784-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/1635e808f9ee/molecules-23-00784-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/4f7059eab6b1/molecules-23-00784-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/038676172f5f/molecules-23-00784-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/419a6acdef13/molecules-23-00784-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/b0da778f9274/molecules-23-00784-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/cd0c73f1c6a8/molecules-23-00784-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/c6c2850d7530/molecules-23-00784-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a27/6017030/1635e808f9ee/molecules-23-00784-g007.jpg

相似文献

1
Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems.研究从鼻腔给药系统中吸收美洛昔康及其盐形式的途径。
Molecules. 2018 Mar 28;23(4):784. doi: 10.3390/molecules23040784.
2
Effect of solubility enhancement on nasal absorption of meloxicam.溶解度增强对美洛昔康鼻腔吸收的影响。
Eur J Pharm Sci. 2016 Dec 1;95:96-102. doi: 10.1016/j.ejps.2016.05.031. Epub 2016 May 31.
3
Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles.含微米或纳米级美洛昔康颗粒的透明质酸钠鼻内制剂的研究。
Int J Pharm. 2015 Aug 1;491(1-2):198-207. doi: 10.1016/j.ijpharm.2015.06.046. Epub 2015 Jun 30.
4
Development of meloxicam salts with improved dissolution and pharmacokinetic behaviors in rats with impaired gastric motility.开发具有改善的溶解性能和药代动力学行为的美洛昔康盐,用于改善胃动力障碍大鼠的状况。
Pharm Res. 2013 Feb;30(2):377-86. doi: 10.1007/s11095-012-0878-2. Epub 2012 Sep 15.
5
Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors.开发具有改善溶解和药代动力学行为的美洛昔康纳米晶体制剂。
Int J Pharm. 2014 Oct 20;474(1-2):151-6. doi: 10.1016/j.ijpharm.2014.08.022. Epub 2014 Aug 17.
6
Improved absorption of meloxicam via salt formation with ethanolamines.通过与乙醇胺形成盐来提高美洛昔康的吸收。
Eur J Pharm Biopharm. 2007 Jan;65(1):99-103. doi: 10.1016/j.ejpb.2006.07.003. Epub 2006 Jul 15.
7
An approach for rapid development of nasal delivery of analgesics--identification of relevant features, in vitro screening and in vivo verification.一种快速开发鼻用镇痛药的方法——相关特征的鉴定、体外筛选和体内验证。
Int J Pharm. 2011 Nov 25;420(1):43-50. doi: 10.1016/j.ijpharm.2011.08.019. Epub 2011 Aug 18.
8
Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.美洛昔康以常规和速溶制剂形式给大鼠给药后的药代动力学:胃肠功能障碍对两种制剂相对生物利用度的影响。
Eur J Pharm Biopharm. 2008 Nov;70(3):889-94. doi: 10.1016/j.ejpb.2008.07.013. Epub 2008 Jul 31.
9
Amorphous Solid Dispersion of Meloxicam Enhanced Oral Absorption in Rats With Impaired Gastric Motility.美洛昔康无定形固体分散体增强胃动力障碍大鼠的口服吸收。
J Pharm Sci. 2018 Jan;107(1):446-452. doi: 10.1016/j.xphs.2017.05.023. Epub 2017 May 24.
10
Improving solubility and pharmacokinetics of meloxicam via multiple-component crystal formation.通过多组分晶体形成提高美洛昔康的溶解度和药代动力学。
Mol Pharm. 2012 Jul 2;9(7):2094-102. doi: 10.1021/mp300169c. Epub 2012 Jun 4.

引用本文的文献

1
Pharmaceutical Salts of Piroxicam and Meloxicam with Organic Counterions.吡罗昔康和美洛昔康与有机抗衡离子形成的药用盐。
Cryst Growth Des. 2022 Oct 21;22(11):6504-6520. doi: 10.1021/acs.cgd.2c00722. eCollection 2022 Nov 2.
2
Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam.用于高效溶解难溶性美洛昔康的智能晶体。
Pharmaceutics. 2022 Jan 21;14(2):245. doi: 10.3390/pharmaceutics14020245.
3
In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin.

本文引用的文献

1
Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects.乳铁蛋白修饰的罗替戈汀纳米粒增强经鼻脑递药:基于 LESA-MS/MS 的药物体内分布、药效学和神经保护作用。
Int J Nanomedicine. 2018 Jan 9;13:273-281. doi: 10.2147/IJN.S151475. eCollection 2018.
2
TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy.壳聚糖 TPGS 交联靶向纳米粒用于有效的脑癌治疗。
Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:167-176. doi: 10.1016/j.msec.2017.02.008. Epub 2017 Feb 4.
3
Development of risperidone liposomes for brain targeting through intranasal route.
胰岛素经鼻腔递送至脑内的固体脂质和 PLGA 纳米粒的体外比较研究。
Int J Mol Sci. 2021 Dec 9;22(24):13258. doi: 10.3390/ijms222413258.
4
Physico-Chemical, In Vitro and Ex Vivo Characterization of Meloxicam Potassium-Cyclodextrin Nanospheres.美洛昔康钾-环糊精纳米球的物理化学性质、体外及离体特性研究
Pharmaceutics. 2021 Nov 6;13(11):1883. doi: 10.3390/pharmaceutics13111883.
5
Comparison of Modern In Vitro Permeability Methods with the Aim of Investigation Nasal Dosage Forms.以研究鼻腔剂型为目的的现代体外渗透方法比较
Pharmaceutics. 2021 Jun 8;13(6):846. doi: 10.3390/pharmaceutics13060846.
6
Physico-Chemical and In Vitro Characterization of Chitosan-Based Microspheres Intended for Nasal Administration.用于鼻腔给药的壳聚糖基微球的物理化学和体外特性研究
Pharmaceutics. 2021 Apr 22;13(5):608. doi: 10.3390/pharmaceutics13050608.
7
Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration.基于质量源于设计的载美洛昔康聚合物胶束鼻腔给药制剂研究
Pharmaceutics. 2020 Jul 24;12(8):697. doi: 10.3390/pharmaceutics12080697.
8
Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity.鼻腔给予含纳米拉莫三嗪鼻粉的吸收研究。
Molecules. 2020 Feb 27;25(5):1065. doi: 10.3390/molecules25051065.
9
Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach.采用质量源于设计方法制备用于鼻脑递送的美洛昔康-人血清白蛋白纳米粒
Pharmaceutics. 2020 Jan 25;12(2):97. doi: 10.3390/pharmaceutics12020097.
经鼻内途径构建利培酮脂质体用于脑部靶向给药。
Life Sci. 2016 Oct 15;163:38-45. doi: 10.1016/j.lfs.2016.08.033. Epub 2016 Sep 1.
4
Improved Flux of Levodopa via Direct Deposition of Solid Microparticles on Nasal Tissue.通过将固体微颗粒直接沉积在鼻组织上来提高左旋多巴的通量。
AAPS PharmSciTech. 2017 Apr;18(3):904-912. doi: 10.1208/s12249-016-0581-4. Epub 2016 Jul 5.
5
Effect of solubility enhancement on nasal absorption of meloxicam.溶解度增强对美洛昔康鼻腔吸收的影响。
Eur J Pharm Sci. 2016 Dec 1;95:96-102. doi: 10.1016/j.ejps.2016.05.031. Epub 2016 May 31.
6
Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.纳米颗粒包裹的他仑氟比治疗药物的鼻内给药:一种针对阿尔茨海默病的潜在脑靶向策略。
Eur J Pharm Sci. 2016 Sep 20;92:224-34. doi: 10.1016/j.ejps.2016.05.012. Epub 2016 May 14.
7
Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation.用于氟哌啶醇鼻脑递送的固体脂质纳米粒:体外药物释放及药代动力学评价
Acta Pharm Sin B. 2014 Dec;4(6):454-63. doi: 10.1016/j.apsb.2014.10.005. Epub 2014 Nov 21.
8
Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.用于神经囊尾蚴病中靶向鼻脑递送的鼻内微乳剂:二十二碳六烯酸的作用
Eur J Pharm Biopharm. 2015 Oct;96:363-79. doi: 10.1016/j.ejpb.2015.08.008. Epub 2015 Aug 28.
9
Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity.鼻内给予载胡椒碱的壳聚糖纳米颗粒作为阿尔茨海默病的脑靶向治疗:优化、生物学疗效及潜在毒性
J Pharm Sci. 2015 Oct;104(10):3544-56. doi: 10.1002/jps.24557. Epub 2015 Jul 3.
10
Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles.含微米或纳米级美洛昔康颗粒的透明质酸钠鼻内制剂的研究。
Int J Pharm. 2015 Aug 1;491(1-2):198-207. doi: 10.1016/j.ijpharm.2015.06.046. Epub 2015 Jun 30.